PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8082343

Do "screening" coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy?

E A Kozak·L K Brath
View original source ↗Export metadata ↓

Abstract

OBJECTIVE: To determine if preprocedure coagulation testing predicts bleeding in patients undergoing flexible fiberoptic bronchoscopy (FOB) with biopsy. DESIGN: Retrospective chart review. SETTING: Southeastern, urban Veteran Affairs Medical Center. MEASUREMENTS AND MAIN RESULTS: Two hundred seventy-four patient charts representing 305 FOB with biopsy were reviewed for clinical predictors of bleeding, prebronchoscopy laboratory abnormalities, and incidence of bleeding complications. Thirty-five patients bled, and 3 had abnormal results of coagulation studies. Normal results of coagulation studies and no clinical risk factors were noted in 68 percent of patients who bled. CONCLUSION: Patients undergoing flexible FOB with biopsy do not benefit from preprocedure coagulation testing.

Explore related subjects

BiopsyBlood Coagulation TestsBronchiBronchial DiseasesBronchoscopyChi-Square DistributionFiber Optic TechnologyHemorrhageHumansPartial Thromboplastin TimePreoperative CarePrevalencePrognosisProthrombin TimeRetrospective StudiesRisk FactorsVirginiaJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E A Kozak, L K Brath. 1994. Do "screening" coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy?. https://doi.org/10.1378/chest.106.3.703

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗